Found: 2
Select item for more details and to access through your institution.
In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1271, doi. 10.3390/cancers11091271
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome due to combination of vemurafenib and cobimetinib for metastatic melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2017, v. 30, n. 2, p. 262, doi. 10.1111/pcmr.12562
- By:
- Publication type:
- Article